eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Laryngology
Vocal Fold Paralysis, Unilateral: Follow-up
Updated: Nov 6, 2008
Outcome and Prognosis
Expected voice outcome following the treatment for unilateral vocal fold paralysis (UVFP) is excellent. Most patients resume normal speaking activities and functions and are able to meet all normal voice demands. Singing is a higher demand than speaking and may not be restored to its premorbid condition. The ability to project one's voice over a large area in a loud manner is also often never fully restored despite optimal medical, behavioral, and surgical treatment. Most patients should have a normal or near-normal speaking voice ability with minimal to no functional limitations of their everyday voice use following successful treatment.
Future and Controversies
Understand that present surgical treatments only provide static improvement to the vocal fold and cannot provide the dynamic activity of the vocal fold to voice production that was present in the premorbid state.
Thus, the future goal of laryngology research is to create a method of dynamic rehabilitation of the paralyzed vocal fold. This goal has been present for decades, and much work has been devoted to the concept of reinnervation of the vocal fold. In humans, the optimal result from reinnervation is a static vocal fold but one that has tone. Often, laryngeal reinnervation is performed simultaneously or sequentially with medialization laryngoplasty. The future of laryngeal reinnervation is unknown but serves as a vast area for research and progress.
More on Vocal Fold Paralysis, Unilateral |
| Overview: Vocal Fold Paralysis, Unilateral |
| Workup: Vocal Fold Paralysis, Unilateral |
| Treatment: Vocal Fold Paralysis, Unilateral |
Follow-up: Vocal Fold Paralysis, Unilateral |
| Multimedia: Vocal Fold Paralysis, Unilateral |
| References |
| « Previous Page | Next Page » |
References
Caton T, Thibeault SL, Klemuk S, et al. Viscoelasticity of hyaluronan and nonhyaluronan based vocal fold injectables: implications for mucosal versus muscle use. Laryngoscope. Mar 2007;117(3):516-21. [Medline].
Zeitels SM, Hillman RE, Desloge RB, et al. Cricothyroid subluxation: a new innovation for enhancing the voice with laryngoplastic phonosurgery. Ann Otol Rhinol Laryngol. Dec 1999;108(12):1126-31. [Medline].
Amin MR. Thyrohyoid approach for vocal fold augmentation. Ann Otol Rhinol Laryngol. Sep 2006;115(9):699-702. [Medline].
Belafsky PC, Postma GN. Vocal fold augmentation with calcium hydroxylapatite. Otolaryngol Head Neck Surg. Oct 2004;131(4):351-4. [Medline].
Bielamowicz S, Stager SV. Diagnosis of unilateral recurrent laryngeal nerve paralysis: laryngeal electromyography, subjective rating scales, acoustic and aerodynamic measures. Laryngoscope. Mar 2006;116(3):359-64. [Medline].
Branski R, Murry T, Rosen CA. Voice Therapy. In: Otolaryngology and Facial Plastic Surgery. 2000:[Full Text].
Carrau RL, Pou A, Eibling DE. Laryngeal framework surgery for the management of aspiration. Head Neck. Mar 1999;21(2):139-45. [Medline].
Hertegard S, Hallen L, Laurent C, et al. Cross-linked hyaluronan versus collagen for injection treatment of glottal insufficiency: 2-year follow-up. Acta Otolaryngol. Dec 2004;124(10):1208-14. [Medline].
Hunsaker DH, Martin PJ. Allergic reaction to solid silicone implant in medial thyroplasty. Otolaryngol Head Neck Surg. Dec 1995;113(6):782-4. [Medline].
Jacobson BH, Johnson A, Grywalski C. The Voice Handicap Index (VHI): Development and Validation. American Journal of Speech-Language Pathology. 1997;6:66-70.
Kwon TK, Buckmire R. Injection laryngoplasty for management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg. Dec 2004;12(6):538-42. [Medline].
Laccourreye O, Papon JF, Kania R, et al. Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient's perspective. Laryngoscope. Mar 2003;113(3):541-5. [Medline].
Miller S. Voice therapy for vocal fold paralysis. Otolaryngol Clin North Am. Feb 2004;37(1):105-19. [Medline].
Milstein CF, Akst LM, Hicks MD, et al. Long-term effects of micronized Alloderm injection for unilateral vocal fold paralysis. Laryngoscope. Sep 2005;115(9):1691-6. [Medline].
Munin MC, Rosen CA, Zullo T. Utility of laryngeal electromyography in predicting recovery after vocal fold paralysis. Arch Phys Med Rehabil. Aug 2003;84(8):1150-3. [Medline].
Noordzij JP, Perrault DF, Woo P. Biomechanics of combined arytenoid adduction and medialization laryngoplasty in an ex vivo canine model. Otolaryngol Head Neck Surg. Dec 1998;119(6):634-42. [Medline].
Rosen CA. Complications of phonosurgery: results of a national survey. Laryngoscope. Nov 1998;108(11 Pt 1):1697-703. [Medline].
Rosen CA. Phonosurgical vocal fold injection: indications and techniques. Operative Techniques in Otolaryngology Head and Neck Surgery. 1998;9(4):203-209. [Medline].
Rosen CA, Thekdi AA. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results. J Voice. Sep 2004;18(3):387-91. [Medline].
Shaw GY, Szewczyk MA, Searle J, et al. Autologous fat injection into the vocal folds: technical considerations and long-term follow-up. Laryngoscope. Feb 1997;107(2):177-86. [Medline].
Umeno H, Shirouzu H, Chitose S, et al. Analysis of voice function following autologous fat injection for vocal fold paralysis. Otolaryngol Head Neck Surg. Jan 2005;132(1):103-7. [Medline].
Further Reading
Keywords
unilateral vocal fold paralysis, UVFP, vocal cord paralysis, neurogenic hoarseness, vocal cord paralysis, larynx, neurogenic hoarseness
Follow-up: Vocal Fold Paralysis, Unilateral